The identification of SOX2, PIWI proteins, and MALAT1 as plasma-based biomarkers represents a promising direction for the non-invasive detection and molecular characterization of colorectal, breast, and prostate cancers; however, further studies incorporating stage-specific analyses are needed to determine their utility in early detection. The gene discussed is MALAT1; the disease is prostate carcinoma.